Engraftment end points
| . | Combined . | MRD . | URD . | P . |
|---|---|---|---|---|
| Neutrophil engraftment, d (range) | 14 (9-17) | 14 (9-17) | 13.5 (11-14) | .2 |
| Platelet engraftment to 20 000/μL, d (range) | 12 (9-47) | 12 (10-47) | 12 (9-25) | .13 |
| Platelet engraftment to 100 000/μL, d (range) | 17.5 (11-189) | 17.5 (11-189) | 17 (12-101) | .32 |
| Time to hospital discharge, d (range) | 19 (14-55) | 19 (15-55) | 19 (14-55) | .95 |
| . | Combined . | MRD . | URD . | P . |
|---|---|---|---|---|
| Neutrophil engraftment, d (range) | 14 (9-17) | 14 (9-17) | 13.5 (11-14) | .2 |
| Platelet engraftment to 20 000/μL, d (range) | 12 (9-47) | 12 (10-47) | 12 (9-25) | .13 |
| Platelet engraftment to 100 000/μL, d (range) | 17.5 (11-189) | 17.5 (11-189) | 17 (12-101) | .32 |
| Time to hospital discharge, d (range) | 19 (14-55) | 19 (15-55) | 19 (14-55) | .95 |
P refers to comparison of MRD and URD groups.